Dianthus Therapeutics | MGTA - Current Assets



Dianthus Therapeutics reported $263.6M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Adcock Ingram Holdings ZAR 5.12B 234.71M Dec/2024
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Avita Medical AUD 57M 15.96M Dec/2024
Celltrion KRW 5.46T 122.95B Mar/2025
Cspc Pharmaceutical CNY 21.89B 4.58B Dec/2024
Dianthus Therapeutics USD 263.6M 17.3M Jun/2025
Divis Laboratories Ltd 100.81B 7.4B Mar/2025
IQVIA Holdings USD 6.35B 434M Jun/2025
Kangmei Pharma CNY 6.9B 6.92M Jun/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Laboratorios Farma EUR 516.3M 26.69M Jun/2025
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.41M 7.26M Dec/2024
Moderna USD 6.17B 595M Jun/2025
Neuren Pharmaceuticals AUD 399.33M 171.29M Dec/2024
Organigram Holdings CAD 277.78M 46.29M Jun/2025
Organon & Co USD 4.62B 247M Jun/2025
Pharma Mar EUR 249.4M 13.39M Jun/2025
Qiagen NV USD 1.82B 76.12M Jun/2025
Revvity USD 2.24B 81.76M Jun/2025
Sartorius EUR 2.17B 7.5M Jun/2025
Sino Biopharmaceutical CNY 24.69B 536.66M Dec/2024
Tectonic Therapeutic USD 290.85M 143.99M Jun/2025
Tilray USD 707.34M 18.54M Nov/2024
Viatris USD 9.77B 152.2M Jun/2025
Xeris Pharmaceuticals USD 185.58M 17.92M Jun/2025
Zz Pientze Pharmaceu 12.29B 113.34M Jun/2025